risk stratification
Risk-Reducing Surgery Improves Outcomes for Young Patients With BRCA1/2-Mutant Breast Cancer
Premium
A global study showed breast cancer patients who underwent preventive surgeries had lower mortality and cancer recurrence risks than those who didn't.
Hackensack Meridien Health Launches Cancer Risk, Early Detection Program; Eyes Multi-Cancer Testing
Premium
Patients will be offered germline genetic testing after an assessment that includes genetic, lifestyle, and other clinical risk factor analysis.
UK's NICE Expands Tumor Profiling Recommendations for Guiding Adjuvant Chemo in Early Breast Cancer
Previously, NICE recommended EndoPredict, Prosigna, and Oncotype DX for node-negative breast cancer only, but the new guidance includes lymph node-positive disease.
Agendia's ImPrint Headed for Prospective Validation as Tool for Guiding Breast Cancer Immunotherapy
Premium
Retrospective data in two breast cancer subtypes have shown the test's ability to identify responders to neoadjuvant immunotherapy with chemo.
PreciseDx Partners With UCLA to Study Cancer Recurrence Risk Assay in TNBC
The researchers will evaluate the ability of the PreciseBreast assay to assess recurrence risk in triple-negative breast cancer patients.
Apr 26, 2023
Jan 17, 2023